• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌性Ras转化的支气管上皮细胞增殖需要NPRL2。

NPRL2 is required for proliferation of oncogenic Ras-transformed bronchial epithelial cells.

作者信息

Chuang Jing-Yuan, Kuo Hsiao-Hui, Wang Pei-Han, Su Chih-Jou, Yih Ling-Huei

机构信息

Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan.

Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, 115, Taiwan.

出版信息

Cell Div. 2024 Jun 24;19(1):22. doi: 10.1186/s13008-024-00126-w.

DOI:10.1186/s13008-024-00126-w
PMID:38915098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11197203/
Abstract

Nitrogen permease regulator-like 2 (NPRL2/TUSC4) is known to exert both tumor-suppressing and oncogenic effects in different types of cancers, suggesting that its actions are context dependent. Here, we delineated the molecular and functional effects of NPRL2 in malignantly transformed bronchial epithelial cells. To do so, we depleted NPRL2 in oncogenic HRas-transduced and malignantly transformed human bronchial epithelial (BEAS2B), Ras-AI-T2 cells. Intriguingly, depletion of NPRL2 in these cells induced activation of mTORC1 downstream signaling, inhibited autophagy, and impaired Ras-AI-T2 cell proliferation both in vitro and in vivo. These results suggest that NPRL2 is required for oncogenic HRas-induced cell transformation. Depletion of NPRL2 increased levels of the DNA damage marker γH2AX, the cell cycle inhibitors p21 and p27, and the apoptosis marker cleaved-PARP. These NPRL2-depleted cells first accumulated at G1 and G2, and later exhibited signs of mitotic catastrophe, which implied that NPRL2 depletion may be detrimental to oncogenic HRas-transformed cells. Additionally, NPRL2 depletion reduced heat shock factor 1/heat shock element- and NRF2/antioxidant response element-directed luciferase reporter activities in Ras-AI-T2 cells, indicating that NPRL2 depletion led to the suppression of two key cytoprotective processes in oncogenic HRas-transformed cells. Overall, our data suggest that oncogenic HRas-transduced and malignantly transformed cells may depend on NPRL2 for survival and proliferation, and depletion of NPRL2 also induces a stressed state in these cells.

摘要

已知氮通透酶调节因子样2(NPRL2/TUSC4)在不同类型的癌症中发挥肿瘤抑制和致癌作用,这表明其作用取决于具体环境。在此,我们阐述了NPRL2在恶性转化的支气管上皮细胞中的分子和功能效应。为此,我们在致癌性HRas转导的恶性转化人支气管上皮(BEAS2B)细胞Ras-AI-T2中敲低NPRL2。有趣的是,在这些细胞中敲低NPRL2会诱导mTORC1下游信号激活,抑制自噬,并在体外和体内损害Ras-AI-T2细胞增殖。这些结果表明,致癌性HRas诱导的细胞转化需要NPRL2。敲低NPRL2会增加DNA损伤标志物γH2AX、细胞周期抑制剂p21和p27以及凋亡标志物裂解的PARP的水平。这些NPRL2敲低的细胞首先在G1期和G2期积累,随后出现有丝分裂灾难的迹象,这意味着敲低NPRL2可能对致癌性HRas转化的细胞有害。此外,敲低NPRL2会降低Ras-AI-T2细胞中热休克因子1/热休克元件和NRF2/抗氧化反应元件指导的荧光素酶报告基因活性,表明敲低NPRL2会导致致癌性HRas转化细胞中两个关键的细胞保护过程受到抑制。总体而言,我们的数据表明,致癌性HRas转导的恶性转化细胞可能依赖NPRL2来生存和增殖,敲低NPRL2也会在这些细胞中诱导应激状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/ee9001d4cbe2/13008_2024_126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/f25e6d906b6f/13008_2024_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/972a9710cd76/13008_2024_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/5ff17b4b99d8/13008_2024_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/8afd781ffbbb/13008_2024_126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/12b454a3d4fb/13008_2024_126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/ee9001d4cbe2/13008_2024_126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/f25e6d906b6f/13008_2024_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/972a9710cd76/13008_2024_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/5ff17b4b99d8/13008_2024_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/8afd781ffbbb/13008_2024_126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/12b454a3d4fb/13008_2024_126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/11197203/ee9001d4cbe2/13008_2024_126_Fig6_HTML.jpg

相似文献

1
NPRL2 is required for proliferation of oncogenic Ras-transformed bronchial epithelial cells.致癌性Ras转化的支气管上皮细胞增殖需要NPRL2。
Cell Div. 2024 Jun 24;19(1):22. doi: 10.1186/s13008-024-00126-w.
2
Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.氮通透酶调节因子样蛋白2的下调激活PDK1-AKT1并促进胶质瘤细胞的恶性生长。
Mol Carcinog. 2016 Nov;55(11):1613-1626. doi: 10.1002/mc.22413. Epub 2015 Oct 12.
3
Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.NPRL2 过表达通过激活 DNA 损伤检查点通路增强结肠癌细胞对伊立替康(CPT-11)的敏感性。
Med Sci Monit. 2018 Mar 9;24:1424-1433. doi: 10.12659/msm.909186.
4
MTH1 expression is required for effective transformation by oncogenic HRAS.致癌性HRAS的有效转化需要MTH1的表达。
Oncotarget. 2015 May 10;6(13):11519-29. doi: 10.18632/oncotarget.3447.
5
NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.NPRL2 通过调节 DNA 修复途径中的关键组件使人类非小细胞肺癌(NSCLC)细胞对顺铂治疗敏感。
PLoS One. 2010 Aug 5;5(8):e11994. doi: 10.1371/journal.pone.0011994.
6
Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells.血清耗竭通过致癌性HRas转化细胞中的一氧化氮合成诱导癌症干细胞样表型。
Oncotarget. 2016 Nov 15;7(46):75221-75234. doi: 10.18632/oncotarget.12117.
7
Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.氮通透酶调节因子样蛋白2增强结肠癌细胞对奥沙利铂的敏感性。
Mol Med Rep. 2015 Jul;12(1):1189-96. doi: 10.3892/mmr.2015.3495. Epub 2015 Mar 13.
8
Tumor suppressor NPRL2 induces ROS production and DNA damage response.抑癌基因 NPRL2 诱导活性氧产生和 DNA 损伤反应。
Sci Rep. 2017 Nov 10;7(1):15311. doi: 10.1038/s41598-017-15497-0.
9
TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling.TUSC4/NPRL2,一种新型的与PDK1相互作用的蛋白,可抑制PDK1酪氨酸磷酸化及其下游信号传导。
Cancer Sci. 2008 Sep;99(9):1827-34. doi: 10.1111/j.1349-7006.2008.00874.x. Epub 2008 Jul 4.
10
FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.FOXO1 通过抑制 E2F1 激活的 NPRL2 表达抑制前列腺癌细胞增殖。
Cell Biol Int. 2021 Dec;45(12):2510-2520. doi: 10.1002/cbin.11696. Epub 2021 Sep 15.

本文引用的文献

1
Challenges and Emerging Opportunities for Targeting mTOR in Cancer.靶向 mTOR 在癌症中的挑战和新机遇
Cancer Res. 2022 Nov 2;82(21):3884-3887. doi: 10.1158/0008-5472.CAN-22-0602.
2
Recent advances and limitations of mTOR inhibitors in the treatment of cancer.mTOR抑制剂在癌症治疗中的最新进展与局限性
Cancer Cell Int. 2022 Sep 15;22(1):284. doi: 10.1186/s12935-022-02706-8.
3
Cell senescence, rapamycin and hyperfunction theory of aging.细胞衰老、雷帕霉素与衰老的功能亢进学说。
Cell Cycle. 2022 Jul;21(14):1456-1467. doi: 10.1080/15384101.2022.2054636. Epub 2022 Mar 31.
4
Molecular mechanisms of heat shock factor 1 regulation.热休克因子 1 调节的分子机制。
Trends Biochem Sci. 2022 Mar;47(3):218-234. doi: 10.1016/j.tibs.2021.10.004. Epub 2021 Nov 19.
5
Soft Agar Colony Formation Assay as a Hallmark of Carcinogenesis.软琼脂集落形成试验作为癌变的一个标志。
Bio Protoc. 2017 Jun 20;7(12):e2351. doi: 10.21769/BioProtoc.2351.
6
Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells.Mdivi-1可诱导MDA-MB-231细胞出现纺锤体异常并增强紫杉醇的细胞毒性。
Cell Death Discov. 2021 May 20;7(1):118. doi: 10.1038/s41420-021-00495-z.
7
mTOR as a senescence manipulation target: A forked road.mTOR 作为衰老干预靶点:分岔的道路。
Adv Cancer Res. 2021;150:335-363. doi: 10.1016/bs.acr.2021.02.002. Epub 2021 Mar 18.
8
The double-edged roles of ROS in cancer prevention and therapy.活性氧(ROS)在癌症预防和治疗中的双刃剑作用。
Theranostics. 2021 Mar 4;11(10):4839-4857. doi: 10.7150/thno.56747. eCollection 2021.
9
Genomic Alterations in -Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors.PI3Kα 抑制剂治疗 -突变型乳腺癌的耐药机制:mTORC1 信号通路激活
Cancer Res. 2021 May 1;81(9):2470-2480. doi: 10.1158/0008-5472.CAN-20-3232. Epub 2021 Mar 8.
10
Regulation of Autophagy Enzymes by Nutrient Signaling.营养信号对自噬酶的调控。
Trends Biochem Sci. 2021 Aug;46(8):687-700. doi: 10.1016/j.tibs.2021.01.006. Epub 2021 Feb 13.